Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience.

[1]  R E Lenkinski,et al.  Prostate cancer: local staging with endorectal surface coil MR imaging. , 1991, Radiology.

[2]  R. Littell.  SAS System for Mixed Models , 1996 .

[3]  H. Hricak,et al.  Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.

[4]  J J Prete,et al.  Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. , 1997, International journal of radiation oncology, biology, physics.

[5]  M A Moerland,et al.  Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. , 1997, International journal of radiation oncology, biology, physics.

[6]  J J Prete,et al.  Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. , 1998, Radiation oncology investigations.

[7]  A. D'Amico,et al.  Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[8]  J J Prete,et al.  Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. , 1998, Radiology.

[9]  A. D'Amico,et al.  Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy. , 1998, Urology.

[10]  L Verhey,et al.  Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[11]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[12]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.

[13]  D. Gladstone,et al.  Prostate seed implant quality assessment using MR and CT image fusion. , 1999, International journal of radiation oncology, biology, physics.

[14]  J. Battermann,et al.  The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  A. Dicker,et al.  Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan. , 2000, Medical physics.

[16]  M Zaider,et al.  Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. , 2000, Cancer journal.

[17]  I. Kaplan.  Minimizing rectal and urinary complications in prostate brachytherapy. , 2000, Journal of endourology.

[18]  M. Sheridan,et al.  The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants , 2000 .

[19]  M. Resnick,et al.  Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[20]  A. D'Amico,et al.  Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. , 2000, Urology.

[21]  W S Bice,et al.  CT and MRI derived source localization error in a custom prostate phantom using automated image coregistration. , 2001, Medical physics.

[22]  H. Hricak,et al.  Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes. , 2001, Radiology.

[23]  Y. Yu,et al.  Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. , 2001, International journal of radiation oncology, biology, physics.

[24]  R. Valicenti,et al.  Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy , 2001, International journal of cancer.

[25]  S. K. Kang,et al.  Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. , 2001, International journal of radiation oncology, biology, physics.

[26]  Evaluation of permanent prostate implants: a pilot study comparing dosimetric impact of inter-observer variability using CT and MRI , 2001 .

[27]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[28]  R. Chou,et al.  Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. , 2002, International journal of radiation oncology, biology, physics.

[29]  P L Roberson,et al.  Comparison of MRI pulse sequences in defining prostate volume after permanent implantation. , 2002, International journal of radiation oncology, biology, physics.

[30]  K. Wallner,et al.  The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. , 2002, International journal of radiation oncology, biology, physics.

[31]  R. Steenbakkers,et al.  Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. , 2003, International journal of radiation oncology, biology, physics.

[32]  Jacob Sosna,et al.  Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. , 2003, Academic radiology.

[33]  J. Rosenwald,et al.  Comparaison de deux méthodes de recalage d'images de scanographie et d'IRM en curiethérapie prostatique. Intérêt pour l'évaluation thérapeutique , 2003 .

[34]  Kemal Tuncali,et al.  Late genitourinary and gastrointestinal toxicity after magnetic resonance image‐guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy , 2003, Cancer.

[35]  M. Resnick,et al.  Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma. , 2003, International journal of radiation oncology, biology, physics.

[36]  Adam P Dicker,et al.  Probability of late rectal morbidity in 125I prostate brachytherapy. , 2003, International journal of radiation oncology, biology, physics.

[37]  M. Kattan,et al.  Importance of implant dosimetry for patients undergoing prostate brachytherapy. , 2003, Urology.

[38]  I. Kaplan,et al.  A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial. , 2004, Brachytherapy.

[39]  P. Wust,et al.  Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  B. Nicolas Bloch,et al.  3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). , 2004, Academic radiology.

[41]  A. Dicker,et al.  Factors predicting for urinary incontinence after prostate brachytherapy. , 2004, International journal of radiation oncology, biology, physics.

[42]  E J Holupka,et al.  An automatic seed finder for brachytherapy CT postplans based on the Hough transform. , 2004, Medical physics.

[43]  M. Haider,et al.  Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy. , 2004, Brachytherapy.

[44]  E. Yorke,et al.  Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer. , 2005, International journal of radiation oncology, biology, physics.

[45]  M. Rubin,et al.  Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule , 2005, Nature Medicine.

[46]  Erratum: Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal, pudendalartery and corpus cavernosum) defined by MRI (International Journal of Radiation Oncology Biology Physics (2005) 61 (20-31)) , 2005 .

[47]  Patrick W McLaughlin,et al.  Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. , 2005, International journal of radiation oncology, biology, physics.

[48]  Robert E Lenkinski,et al.  Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.